Literature DB >> 23869580

Factors affecting umbilical cord blood stem cell suitability for transplantation in an in utero collection program.

Christine L Keersmaekers1, Brian A Mason, Jan Keersmaekers, Matthew Ponzini, Ryan A Mlynarek.   

Abstract

BACKGROUND: The greatest limiting factor in the use of umbilical cord blood (UCB) for transplantations is the number of stem cells available in any given collected unit. This study examines maternal, neonatal, and obstetric factors that influence the suitability for banking and transplantation of UCB units collected in utero. STUDY DESIGN AND METHODS: This study examined 7839 UCB units collected in utero at two hospitals from August 1, 2008, to August 31, 2011. The variables were collected from cord blood records, patient charts, delivery records, and data processed by StemCyte, Inc. (Covina, CA), our parent bank. The mean total nucleated cell (TNC) count between units selected for transplant and those banked but not selected for transplant were also compared.
RESULTS: Of the 11 variables evaluated, six had a significant influence on the acceptable banking TNC count of at least 90 × 10(7) . Of these, cord blood volume was the best predictor. The other variables that were predictors of the acceptable TNC count of significance were gestational age, infant race, parity, birthweight, and infant sex. The minimal bankable TNC count for banking is considerably lower than the mean TNC count of units actually selected for transplantation.
CONCLUSION: Maternal, neonatal, and obstetric factors can all influence the acceptability of a cord blood unit collected in utero for banking. Furthermore, units with high TNC counts are more likely to be selected for banking. Identifying these variables in potential donors can likely increase the number of adequate collections.
© 2013 American Association of Blood Banks.

Entities:  

Mesh:

Year:  2013        PMID: 23869580     DOI: 10.1111/trf.12340

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  7 in total

1.  Circadian and circannual variations in cord blood hematopoietic cell composition.

Authors:  Sophie Servais; Etienne Baudoux; Bénédicte Brichard; Dominique Bron; Cécile Debruyn; Didier De Hemptinne; Véronique Deneys; Jean-Michel Paulus; Jean-Pierre Schaaps; Jean-Remy Van Cauwenberge; Laurence Seidel; Alain Delforge; Yves Beguin
Journal:  Haematologica       Date:  2014-09-26       Impact factor: 9.941

2.  Cord blood collection and banking from a population with highly diverse geographic origins increase HLA diversity in the registry and do not lower the proportion of validated cord blood units: experience of the Marseille Cord Blood Bank.

Authors:  C Bordoni; J Magalon; C Gilbertas; M Gamerre; P Le Coz; M Berthomieu; C Chabannon; J Di Cristofaro; C Picard
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

3.  Good practices in collecting umbilical cord and placental blood.

Authors:  Lauren Auer Lopes; Elizabeth Bernardino; Karla Crozeta; Paulo Ricardo Bittencourt Guimarães
Journal:  Rev Lat Am Enfermagem       Date:  2016-08-18

4.  [Influence of maternal and infant factors on CD34+ hematopoietic stem/progenitor cells in umbilical cord blood].

Authors:  Jing He; Yue-Ming Yang; Ling Liu; Dong Wang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2021-01

5.  Association between maternal and fetal factors and quality of cord blood as a source of stem cells.

Authors:  Rodrigo Dias Nunes; Flávia Maria Zandavalli
Journal:  Rev Bras Hematol Hemoter       Date:  2014-11-26

Review 6.  Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility.

Authors:  Olivier Hequet
Journal:  J Blood Med       Date:  2015-02-18

7.  Increased Expression of BIRC2, BIRC3, and BIRC5 from the IAP Family in Mesenchymal Stem Cells of the Umbilical Cord Wharton's Jelly (WJSC) in Younger Women Giving Birth Naturally.

Authors:  Paulina Gil-Kulik; Małgorzata Świstowska; Adrianna Kondracka; Piotr Chomik; Arkadiusz Krzyżanowski; Anna Kwaśniewska; Mansur Rahnama; Janusz Kocki
Journal:  Oxid Med Cell Longev       Date:  2020-04-08       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.